RHBDD1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, RHBDD1 is highly expressed in human cancers, such as colorectal cancer, glioblastoma, hepatocellular carcinoma, and chronic myeloid leukaemia; silencing RHBDD1 inhibits the proliferation of these tumour cells (16-19).